Arthrex’s TightRope implant has pediatric-specific instrumentation and is now the only ACL fixation device cleared for young patients, according to a news release.
Frank Cordasco, MD, and Daniel Green, MD, of New York City-based Hospital for Special Surgery helped develop the instruments for pediatric use.
“The expansion of Arthrex’s knee ligament portfolio to include pediatric- and young-adolescent-specific instrumentation and implants, along with the new indications cleared by the FDA, represents a substantial improvement on existing treatment options in this high-risk population of athletes,” Dr. Cordasco said in the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
